Coeptis Therapeutics received a notice from Nasdaq stating that it is not currently in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
AI Assistant
Z SQUARED INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.